胰岛素促泌剂是目前治疗2型糖尿病的一类主要口服降糖药，是非肥胖及部分肥胖2型糖尿病的一线治疗药物。

Insulin secretagogues presently is not only a kind of major oral hypoglycemic drugs but also the first-line treatment for non-obese and obese type 2 diabetic mellitus(T2DM).

youdao

百泌达是FDA批准的治疗2型糖尿病的首个GLP - 1受体激动剂药物。

BYETTA is the first FDA-approved GLP-1 receptor agonist for the treatment of type 2 diabetes.

youdao

GLP - 1分泌增加是通过人工甜味剂刺激L细胞上的甜味受体调节的。

This increase in GLP-1 secretion may be mediated via stimulation of sweet-taste receptors on L-cells by artificial sweetener.

youdao